Melqart Asset Management’s Avidity Biosciences RNAM Stock Holding History

Melqart Asset Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-355,691	Closed	-$25.7M	–	56
2025 Q4	$25.7M	Buy	+355,691	New	+$23M	2.53%	17

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Melqart Asset Management's RNAM Position: Q1 2026 in Review

Melqart Asset Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 355,691 shares — an estimated $25.7M sold.

Melqart Asset Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $25.7M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Melqart Asset Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Melqart Asset Management sold 355,691 Avidity Biosciences shares in Q1 2026, an estimated $25.7M.
Melqart Asset Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Melqart Asset Management's Avidity Biosciences position peaked at $25.7M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Melqart Asset Management's 13F filing for Q1 2026, filed 12 May 2026.